MC Services AG

@MCServicesAG

Health care communicators: We know how to tell your story and convey it to investors, bankers, analysts, the media and your peers.

Munich/Dusseldorf
Vrijeme pridruživanja: prosinac 2009.

Tweetovi

Blokirali ste korisnika/cu @MCServicesAG

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MCServicesAG

  1. 4. velj

    with and its partner . The two companies have a strategic collaboration to co-develop personalized , which will be evaluated in a Phase I clinical trial in various .

    Poništi
  2. 4. velj

    Today is ! Cancer is the 2nd leading cause of death worldwide. Many companies, including some of our clients, , , , and , are developing cutting-edge anti-tumor treatments to win the battle against cancer.

    Poništi
  3. proslijedio/la je Tweet
    4. velj

    Today is . We are fueled by our mission to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases.

    Poništi
  4. 4. velj

    Today is ’s 20th anniversary - uses the power of from the death cap mushroom for the development of Antibody Targeted Conjugates () against . Read more 👉

    Poništi
  5. 4. velj

    On we recognize cancer treatment requires innovation. Our client is a pioneer in the field using to fight cancer from within. – learn more about their therapy system here

    Poništi
  6. 4. velj

    February 4th is . 20 years ago, 6 cancer experts established this day to acknowledge the impact of cancer and build an alliance against “fear, ignorance and complacency” - together with , , and

    Poništi
  7. 4. velj

    will make an impact to create a future without cancer with its immunotherapy T-Guard currently in Ph 3 trial in the U.S. to treat SR-aGVHD in blood cancer patients following an allogeneic stem cell transplant. ,

    Poništi
  8. 4. velj

    Today is - with ! Its lead candidate is advancing in clinical development and targeting different important indications like and metastatic . Discover more 👉

    Poništi
  9. proslijedio/la je Tweet
    4. velj

    : has cooperated with the Paracelsus Clinic in Zwickau since last year. Prof. Dr. Warnke is now successfully treating patients with our NanoTherm therapy system.

    Poništi
  10. proslijedio/la je Tweet
    4. velj

    20 years ago, was established to acknowledge the impact of cancer on human life and society. Aiming to fight , MorphoSys is developing therapies

    Poništi
  11. 4. velj

    Today is with ’s Antibody Targeted Conjugate () technology designed to fight -> the -ATAC -101 against . Discover More👉

    Poništi
  12. proslijedio/la je Tweet
    1. velj

    German CDMO Forms Smart U.S. Subsidiary: In the pharmaceutical industry many products have been launched using wellestablished processes. But if new products are to reach greater heights these processes must be improved. Whats needed is the boost that…

    Poništi
  13. proslijedio/la je Tweet
    3. velj

    Knowledge and science have no borders. Scientists and experts of all World are working together to find a solution to beat . German scientists are also contributing by working and sharing results.

    Poništi
  14. proslijedio/la je Tweet
    2. velj

    As the spreads, fear is fueling racism and - CNN. This is not the they. We need to fight and not against each other.

    Poništi
  15. 31. sij

    . Highlights Looming Clinical Trial Issues for Biotech and Pharma Companies Post UK Departure from The EU

    Poništi
  16. 31. sij

    Next week is - Read how and partnered up to develop Antibody Targeted Amanitin Conjugates () for targeted of patients. Discover more 👉

    Poništi
  17. 31. sij

    Next week is - is developing innovative oral T-cell for patients suffering from by targeting cancer-related antigens. Discover more about its lead candidate and pipeline 👉

    Poništi
  18. 30. sij
    Poništi
  19. proslijedio/la je Tweet
    29. sij

    Atriva Fast Tracks Antiviral Candidate As Coronavirus Arrives In Germany

    Poništi
  20. proslijedio/la je Tweet
    29. sij

    The world is under virus attack, but German scientists are already on the move. spoke with Prof. Dr. Ludwig, developer of ’ host-targeting candidate, , about pandemic threats like , SARS, MERS and .

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·